Edition:
United Kingdom

Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

102.03USD
22 Jun 2018
Change (% chg)

$-0.07 (-0.07%)
Prev Close
$102.10
Open
$102.15
Day's High
$102.59
Day's Low
$101.25
Volume
58,442
Avg. Vol
32,751
52-wk High
$114.63
52-wk Low
$56.76

Chart for

About

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $694.57
Shares Outstanding(Mil.): 7.23
Dividend: --
Yield (%): --

Financials

  HSKA.OQ Industry Sector
P/E (TTM): 49.29 32.19 32.74
EPS (TTM): 1.95 -- --
ROI: 15.81 13.89 14.38
ROE: 17.12 16.72 16.08

BRIEF-Heska Reports Q1 Earnings Per Share Of $0.28

* Q1 EARNINGS PER SHARE VIEW $0.35 -- THOMSON REUTERS I/B/E/S

04 May 2018

BRIEF-Heska Reports ‍Q4 Earnings Per Diluted Share Was $0.63​

* Q4 EARNINGS PER SHARE VIEW $0.57, REVENUE VIEW $41.0 MILLION -- THOMSON REUTERS I/B/E/S

28 Feb 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.51 +0.21
Novartis AG (NOVN.S) CHF75.60 +0.10
Merck & Co., Inc. (MRK.N) $61.47 +0.29
Bayer AG (BAYGn.DE) €98.84 +2.45
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €69.01 +1.30
Eli Lilly And Co (LLY.N) $85.92 -0.15
IDEXX Laboratories, Inc. (IDXX.OQ) $222.90 +0.99
Virbac SA (VIRB.PA) €120.20 -1.60
Vetoquinol SA (VETO.PA) €49.80 -0.40

Earnings vs. Estimates